Home LiteratureArticle Details
PMID: 7053190 Published · ppublish English Journal Article

Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Gastroenterology ·Vol. 78 ·No. 3 ·1980-03-00 ·Pages 431-4

Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T

Abstract

Twenty patients with antimicrobiol-associated diarrhea had a symptomatic relapse after oral vancomycin therapy. All patients had stool examinations which implicated C. difficile as the causative agent, and 16 had pseudomembranous colitis. Clinical courses were characterized by resolution of symptoms with recurrence of diarrhea at 4--21 days after vancomycin was discontinued. Studies of stools collected sequentially showed that vancomycin failed to eliminate C. difficile despite susceptibility to this agent with in vitro testing. A review of our records shows the incidence os symptomatic relapse is approximately 14%. This experience emphasizes the importance of adequate follow-up in patients treated with oral vancomycin for antibiotic-associated diarrhea or colitis due to C. difficile.

MeSH Terms
Anti-Bacterial Agents/adverse effects Clostridium/isolation & purification Clostridium Infections/drug therapy Cytotoxins/isolation & purification Enterocolitis, Pseudomembranous/chemically induced,drug therapy,microbiology Follow-Up Studies Humans Microbial Sensitivity Tests Recurrence Vancomycin/administration & dosage
Chemicals
Anti-Bacterial Agents Cytotoxins Vancomycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bartlett J G
Tedesco F J
Shull S
Lowe B
Chang T
Article Info
Journal
Gastroenterology
Abbr.
Gastroenterology
ISSN
0016-5085
Published
1980-03-00
Pages
431-4
Language
English
Region
United States
NLM ID
0374630
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]